This book provides a comprehensive guide to the major issues surrounding the development of anxiolytic drugs. Written by authors well known for their extensive experience in the field of drug development, this book will be of interest to the academic community frequently involved in clinical trials of potential anxiolytic compounds, as well as to the pharmaceutical industry in the formulation of drug development programs.